1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow EOM Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms EOM613 - COVID-19 Pneumonia, COVID-19 Respiratory Infection | Phase 1 | Unknown | EOM Pharmaceuticals | 40 | 2021-08-09 | 2022-01-28 |
COVID-19 (1)
EOM613 (1)
Brazil (1)
Florentino Cardoso Filho, MD, PhD (1) · Frank L Douglas, PhD, MD (1) · Irach Taraporewala, PhD (1)